Microvascular dysfunction: Determinants and treatment, with a focus on hyperglycemia

Individuals with prediabetes or type 2 diabetes have an increased risk of diseases that are partly or entirely of microvascular origin (e.g. (lacunar) stroke, depression, cognitive decline, retinopathy, heart failure, chronic kidney disease, and neuropathy). These diseases are expressions of advance...

Full description

Bibliographic Details
Main Authors: Alfons J.H.M. Houben, Coen D.A. Stehouwer
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:Endocrine and Metabolic Science
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666396120300273
Description
Summary:Individuals with prediabetes or type 2 diabetes have an increased risk of diseases that are partly or entirely of microvascular origin (e.g. (lacunar) stroke, depression, cognitive decline, retinopathy, heart failure, chronic kidney disease, and neuropathy). These diseases are expressions of advanced microvascular dysfunction (MVD). Yet, MVD may develop already early and contribute to impaired insulin-mediated glucose uptake and subsequent metabolic insulin resistance, characterized by hyperglycemia. However, apart from hyperglycemia being a consequence of MVD, hyperglycemia can also (further) impair microvascular function, constituting a vicious cycle. In this review we shall discuss important evidence showing that MVD may precede and predict (pre)diabetes and related co-morbidities, and discuss the important determinants of early MVD. In addition, we shall discuss hyperglycemia being both a cause and consequence of MVD. Finally, we shall focus on prevention and treatment strategies for MVD.
ISSN:2666-3961